Friday, 04 September 2026 08:35 PM
Advertorial
As interest in whole-leaf kratom and 7-OH continues shaping buyer research in 2026, this DEFY IT Health Kratom review examines Level-Up vs. Respawn, the brand-stated *Mitragyna speciosa* ingredient profile, current pricing, batch-testing disclosures, refund terms, and the key differences consumers may want to compare before choosing a format for their routine.
EL CAJON, CA / ACCESS Newswire / September 4, 2026 / Advertising Disclosure: This is a paid advertorial. A commission may be earned from qualifying purchases made through links below, at no extra cost to you. Statements about DEFY IT reflect the manufacturer's own claims unless we say otherwise, kratom is not FDA-approved or recognized as a lawful dietary supplement, and this article isn't medical advice. Full disclosure details are at the bottom of this article.
DEFY IT Kratom Customer Research 2026: Before You Choose Level-Up or Respawn, Read This About 7-OH, Pricing and the Fine Print
DEFY IT's pitch is aimed at a specific kind of week: long gaming sessions, demanding workouts, deadline-heavy creative work, back-to-back professional schedules - or simply comparing whole-leaf kratom against extracts. If that's why DEFY IT caught your attention, the real questions aren't just what Level-Up and Respawn are called. They're what each product actually contains, how DEFY IT distinguishes the two, what its 7-OH claims mean now that the DEA has opened a scheduling action targeting concentrated 7-OH, what the current pricing and guarantee actually look like, and which parts of the performance story are manufacturer positioning rather than independently established outcomes. Here's the quick version, then the full breakdown.
Key Takeaways
Level-Up vs. Respawn: DEFY IT positions Level-Up around focus and endurance, Respawn around recovery and reset - both are the same whole-leaf tablet with the same ingredient list, just different brand framing.
What you're actually buying: pressed whole-leaf Mitragyna speciosa tablets, 300 mg of leaf per 500 mg tablet, sold by Ethos Natural Medicine LLC dba Etha Natural Medicine.
The 7-OH question: DEFY IT states 7-OH is kept at trace, naturally occurring levels, not concentrated - and the DEA's July 2026 scheduling action explicitly targets concentrated/synthetic 7-OH, not natural whole-leaf kratom like DEFY IT describes.
What it actually costs: pricing didn't match across DEFY IT's own pages at the time of this review - $17.49-$18.49 per product, $49.99-$52.99 for the bundle - so confirm the live price before checkout.
If you change your mind: ETHA's 30-day money-back guarantee is real, but conditional - original packaging, usage limits, and first-purchase eligibility all apply.
What regulators say: DEFY IT is not an FDA-approved drug, kratom is not lawfully marketed as a dietary supplement, and a California Proposition 65 lead-exposure warning appears on ETHA's checkout pages.
What DEFY IT's own shipping list misses: independent research found state kratom bans - including Tennessee's, effective July 1, 2026 - that aren't reflected on either of DEFY IT's own restriction lists.
Want the live numbers before reading further? See DEFY IT's current pricing and bundle listing here, then come back for the parts the label doesn't spell out.
Who Makes DEFY IT?
DEFY IT Health is marketed as a brand of ETHA. Per the site's own terms of service, the operator is Ethos Natural Medicine LLC, doing business as Etha™ Natural Medicine, based in El Cajon, California. Checkout for both Level-Up and Respawn routes to ethanaturals.com rather than completing on the defyithealth.com landing page - consistent with DEFY IT operating as a product line under the larger ETHA storefront rather than as a separately operated retailer. An identifiable operating entity is a useful transparency signal, but it doesn't by itself establish that a product performs as marketed - that's covered later in this review.
What Is DEFY IT?
DEFY IT is a line of pressed whole-leaf kratom tablets sold under two formulas, Level-Up and Respawn. The quick specs, per the brand's own product pages:
Format: pressed tablets rather than loose powder - DEFY IT says this supports more consistent, measurable servings.
Package size: 30 grams / 100 tablets per bag, for both formulas.
Active ingredient: 300 mg Mitragyna speciosa leaf per 500 mg tablet.
Positioning: Level-Up for focus and endurance, Respawn for recovery and reset - marketed to gamers, athletes, creators, and professionals with demanding schedules.
DEFY IT Level-Up Review
Level-Up is sold by the brand as its "Endurance & Focus" tablet.
DEFY IT's positioning: clarity, sustained drive, and reaction-time support, described as "full-spectrum botanical balance." This is manufacturer marketing, not an independently established clinical outcome for the finished product.
DEFY IT landing-page price: $17.49 for 30 grams / 100 tablets, at the time of this review.
ETHA checkout price: $18.49 for the same package size - see the pricing section below for the full discrepancy.
Label: 300 mg Mitragyna speciosa leaf per tablet.
DEFY IT Respawn Review
Respawn is positioned by DEFY IT around post-exertion recovery and reset.
Landing-page positioning: muscle restoration and acute focus after activity.
ETHA checkout positioning: more symptom-specific - "relief from occasional discomfort, muscle tension, and inflammation support." Treat this the same as any other manufacturer claim: brand positioning, not a demonstrated treatment outcome.
DEFY IT landing-page price: $17.49 for 30 grams / 100 tablets.
ETHA checkout price: $18.49 for the same package.
Label: 300 mg Mitragyna speciosa leaf per tablet, identical to Level-Up.
Level-Up vs. Respawn
DEFY IT markets Level-Up toward focus and endurance, and Respawn toward recovery and reset - a manufacturer distinction, not an independently confirmed functional difference. Side by side:
Positioning: Level-Up for focus/endurance; Respawn for recovery/reset, per the brand's framing.
Active ingredient: identical - 300 mg Mitragyna speciosa leaf per tablet in both.
Package size: identical - 30 grams / 100 tablets.
Price: identical at each respective source (landing page or checkout page) - see the pricing section.
Bundle: a "dual-mode performance stack" combining two packages of each (four total), $49.99 on the landing page at the time of this review (discounted from a displayed $69.99).
Whether Level-Up, Respawn, or the bundle is the better starting point is a decision for the buyer and, ideally, their healthcare provider - not an editorial recommendation this review can substantiate. If you're weighing the two, compare Level-Up and Respawn side by side on DEFY IT's site before deciding.
DEFY IT Ingredients
The supplement facts panel for both Level-Up and Respawn lists one active botanical ingredient:
Mitragyna speciosa leaf: 300 mg per 500 mg tablet; daily value not established.
Formulation: DEFY IT markets this as the plant's naturally occurring alkaloid profile, rather than isolated or concentrated compounds.
This review did not independently verify a full excipient or inactive-ingredient list beyond what's stated on the label images available at the time of research.
Mitragynine
Mitragynine, often abbreviated MIT, is the major alkaloid naturally present in kratom leaf and is studied in the pharmacological literature for its receptor activity. DEFY IT connects that general mechanism to its focus and performance marketing. That general pharmacology doesn't, on its own, establish the specific performance outcomes DEFY IT markets for its finished tablets, so we don't draw that line for readers either.
7-Hydroxymitragynine (7-OH)
DEFY IT states that its tablets keep 7-hydroxymitragynine, or 7-OH, at naturally occurring trace levels, distinguishing its whole-leaf products from extract or "shot" formats it describes as carrying elevated, concentrated 7-OH content. This reflects a real regulatory dividing line: authorities have scrutinized concentrated or enhanced 7-OH products far more heavily than traditional whole-leaf kratom, where 7-OH occurs naturally in comparatively small amounts (see the DEA section below). That said, this distinction doesn't mean traditional whole-leaf kratom has been evaluated or approved by the FDA, and this review did not independently confirm the exact 7-OH concentration in a specific DEFY IT batch certificate of analysis.
Whole-Leaf Kratom vs. Extracts
DEFY IT publishes its own comparison between whole-leaf tablets and extract products. What DEFY IT says, versus what can independently be established, are two separate columns:
Composition: DEFY IT describes its tablets as a full-spectrum alkaloid product, versus what it calls chemically concentrated actives in extracts. This is the brand's characterization of its own formulation category, not an independently tested comparison.
7-OH levels: DEFY IT states its trace 7-OH content reflects natural balance, versus elevated levels it attributes to some extract products - a distinction with real regulatory basis, though not independently verified for this specific product's current batches.
Subjective experience: DEFY IT describes its tablets as producing steady, continued energy without jitters or crashes, versus what it calls a sharp onset and rapid crash from extracts. These are manufacturer descriptions of subjective experience, not a guarantee of how any individual user will respond.
Testing transparency: DEFY IT says its batches are supported by QR-code certificates of analysis; this review did not independently pull and confirm a specific batch COA.
Regulatory framing: DEFY IT describes its products as "DSHEA and KCPA compliant" and characterizes extracts as carrying greater regulatory risk. DSHEA compliance isn't the same thing as FDA approval and doesn't establish that kratom qualifies as a lawful dietary ingredient under current FDA guidance - see the FDA status section below. The Kratom Consumer Protection Act (KCPA) is also not one federal law; it's model legislation individual states have adopted with their own specific terms, so a blanket "KCPA compliant" claim doesn't by itself specify which state's version, if any, is being referenced.
None of the above should be read as this publication concluding that DEFY IT is safer, cleaner, or more effective than any extract product - those are comparative claims that would require independent substantiation this review doesn't have.
DEFY IT Lab Testing and Certificates of Analysis
DEFY IT says its batches are:
Pasteurized and filtered
Tested in batches for purity
Backed by certificates of analysis accessible via QR code or bag number on the packaging
If implemented as described by the brand, this gives consumers a mechanism for reviewing batch-specific documentation rather than relying solely on general product-page claims. Lab testing and an available COA system don't by themselves establish that a given batch is free of contaminants, clinically effective, or FDA-tested - those are separate claims we're not making here. We did not independently pull and verify a specific Level-Up or Respawn certificate of analysis; readers who want to confirm lab name, test date, lot number, mitragynine and 7-OH concentrations, and contaminant screening should look up their specific batch's COA directly before use.
What DEFY IT Claims About Focus, Energy, and Recovery
DEFY IT's marketing describes its tablets as producing:
Smooth-onset energy that builds rather than spikes
Centered focus without jitters or crashes
Physical recovery "that feels earned, not induced"
These are presented on the brand's own page as what a user may "feel" - a fundamentally different claim than a demonstrated clinical outcome - and none of these statements have been evaluated by the FDA, a disclosure the company itself includes on its site.
DEFY IT Safety, Side Effects, and Dependence
DEFY IT's marketing describes its whole-leaf alkaloid profile as creating a "natural safety ceiling" that the company says stabilizes energy, clarity, and calm "without overdependence or crash." This is a manufacturer safety characterization, not an independently established clinical finding, and shouldn't be treated as an established fact. Regulatory context worth weighing alongside that claim:
The FDA has identified potential adverse effects associated with kratom and kratom-derived products as part of its ongoing review of the category, including concerns related to dependence and withdrawal.
This review does not speculate about the side-effect incidence of DEFY IT's specific finished product - that would require independent clinical data this review doesn't have.
Consumers should weigh the broader regulatory context rather than rely solely on a manufacturer's characterization of its own safety profile.
Medication, Pregnancy, and Driving Warnings
DEFY IT's own product disclaimers include:
Consult a healthcare professional before use if you have or suspect a medical condition
Extra caution flagged for anyone taking antidepressants, anti-anxiety medications, diabetes medications, narcotics, blood pressure medication, sedatives, tranquilizers, or asthma medication
Not for use during pregnancy or lactation
Not for use by anyone under 18
Do not drive or operate machinery after use
Keep out of reach of children
Consumers taking medications or managing medical conditions should discuss kratom use with an appropriate healthcare professional rather than rely on this article for individualized guidance; this review does not provide dosing or drug-interaction advice.
Is DEFY IT FDA Approved?
No. DEFY IT's own site discloses that its statements have not been evaluated by the FDA and that its botanicals "have not been classified and approved" by the FDA as a dietary ingredient. That familiar supplement-style disclaimer understates the FDA's current position, which is more specific: the FDA states there are no FDA-approved prescription or over-the-counter drug products containing kratom or its known alkaloids, and that kratom is not lawfully marketed in the United States as a dietary supplement. Because of that regulatory status, this review avoids describing DEFY IT's tablets as a conventional "dietary supplement," using terms such as kratom botanical product or whole-leaf kratom tablet product instead. Neither a QR-accessible COA, a DSHEA-compliance claim, nor GMP-style language on a product page establishes FDA approval, registration, or endorsement.
DEA's 2026 Action on Concentrated 7-OH - and Where DEFY IT Fits
Key facts, confirmed directly from FDA and DEA public statements:
Date: July 1, 2026 - the DEA issued two Notices of Intent to begin temporary scheduling.
What's targeted: 7-hydroxymitragynine (7-OH) above a specified concentration threshold, plus three related synthetic compounds - mitragynine pseudoindoxyl, MGM-15, and MGM-16 - proposed for Schedule I.
Explicit exclusion: both agencies state this action is not intended to apply to natural, whole-leaf kratom containing only naturally occurring trace levels of 7-OH.
Current status: a public comment period on the proposed threshold is open, and any temporary scheduling order would follow a further Attorney General determination - this is an active, unfinished regulatory process, not a settled rule.
DEFY IT states that its Level-Up and Respawn tablets are made from whole, pressed kratom leaf containing only naturally occurring trace levels of 7-OH rather than added or concentrated 7-OH. Based on that description, DEFY IT's stated formulation would fall outside the category regulators have targeted in this specific action. That's a characterization based on the company's own description of its formulation, not on independent testing of DEFY IT's current batches against the proposed threshold, and it doesn't mean DEFY IT or kratom generally has been declared legal, safe, or FDA-approved - only that concentrated and synthetic 7-OH products are the stated focus of this particular DEA action. Because this is a fast-moving regulatory process, readers should check for current updates rather than treat this status as permanent. Want to see how DEFY IT documents its own 7-OH and COA claims?
California Proposition 65 Warning
ETHA's product checkout pages for both Level-Up and Respawn display a California Proposition 65 warning: "Consuming this product can expose you to lead, a naturally occurring substance, which is known to the State of California to cause cancer, birth defects, or other reproductive harm." That warning did not appear on the defyithealth.com marketing landing page itself at the time of this review - only on ETHA's own checkout listings. A Proposition 65 warning is a California consumer-disclosure notice and, standing alone, doesn't establish the amount of lead present in a particular DEFY IT lot or independently determine the product's overall safety profile.
DEFY IT Pricing and Bundle
Prices at the time of this review, which did not match across the brand's own pages:
DEFY IT landing page: Level-Up $17.49, Respawn $17.49, dual-mode bundle $49.99 (displayed reference price $69.99).
ETHA storefront checkout: Level-Up $18.49, Respawn $18.49, Defy It Bundle $52.99 (displayed reference price $69.96).
Because these pages were not synchronized, treat all quoted prices as time-sensitive and confirm the checkout amount before ordering. The landing page also displayed promotional codes at the time of this review, including one advertised as an additional discount and one for free shipping; because promotional codes and pricing change frequently, confirm the current live price and any active promotion directly on the seller's site immediately before checkout rather than relying on any figure or code stated here or in any third-party content. Separately, the brand describes the bundle as pressed in limited batches with its next restock roughly 30 days out - a real supply detail from DEFY IT's own product page, not something this review is adding for effect, and one more reason to confirm current availability rather than assume it'll be there later.
Ready to see the actual numbers for yourself? Check current Level-Up, Respawn, and bundle pricing here - and confirm availability and seller terms before you check out.
DEFY IT Refund Policy and Money-Back Guarantee
ETHA advertises a "30-Day Money Back Guarantee," described as allowing a customer to test the product and receive a refund if it doesn't work for them. The published conditions attached to that guarantee:
Refund requests must be made within 30 days of purchase.
Single-item orders must be returned in original packaging, with no more than half the product used.
The guarantee applies to first-time purchases; a subsequent order reportedly requires proof of a manufacturer defect.
Multi-item orders: only one package may be opened, and the majority of total contents must remain unused.
Purchases made through third-party resellers are directed back to that reseller rather than to ETHA directly.
The buyer is responsible for return shipping costs, which can be deducted from the refund if ETHA provides the shipping label.
This is not "risk-free" or an unconditional guarantee - it's a conditional, time-limited policy, and readers should review the current terms directly with ETHA before purchasing based on the expectation of a refund.
Shipping and Legal Restrictions
DEFY IT ships via USPS and UPS, with orders typically shipped within 24 hours on business days, and free-shipping thresholds available at higher order values (excluding certain products such as brewed kratom drinks and live plants). The brand's own published policies disagree with each other on which states are restricted:
Terms of service list: Alabama, Arkansas, Indiana, Tennessee, Vermont, and Wisconsin.
Shipping policy list: Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, and Louisiana - plus specific restricted cities, counties, and countries.
This review does not attempt to resolve which list is authoritative. Independent research for this review also found additional state-level kratom bans that aren't reflected on either list:
Tennessee - banned effective July 1, 2026 (Public Chapter 950, commonly called "Matthew Davenport's Law"); already on the terms-of-service list, but missing from the shipping policy.
Connecticut - banned effective March 25, 2026; on neither list.
Kansas and North Dakota - listed as full-ban states by multiple kratom-industry legal trackers; on neither list.
This is a concrete example of why a seller's published restriction list shouldn't be treated as the final word on legality: state kratom law changed multiple times in 2026 alone. A seller's shipping restriction is also not the same thing as a jurisdiction's legal prohibition - both readers and sellers should verify current state law directly rather than rely on any single list as complete or current.
DEFY IT Customer Reviews and Testimonials
DEFY IT's site publishes customer testimonials describing a range of individual experiences, including general wellness, relaxation, and focus during physical activity. The company includes a disclaimer beneath its testimonials stating that individual results vary, that the experiences shown aren't necessarily typical of what any other consumer might experience, and that testimonials aren't intended to be read as claims that its products diagnose, treat, cure, mitigate, or prevent any disease. We aren't restating specific customer testimonials as evidence of the product's effects here, particularly where those testimonials describe medical conditions or symptom relief - testimonials are anecdotal, and a "results may vary" disclaimer doesn't substantiate an otherwise unsupported health claim.
Is DEFY IT Legit? What Can Actually Be Verified
What can be independently confirmed:
An identifiable operator - Ethos Natural Medicine LLC dba Etha Natural Medicine - with a physical business address.
A working checkout system on an established e-commerce platform.
Published shipping and refund policies.
Product labels listing a single active botanical ingredient.
A stated system for accessing batch certificates of analysis.
What remains unverified by this review:
The specific contents of any individual batch COA.
The accuracy of DEFY IT's comparative claims against extract products.
Any of the subjective effects the brand markets.
"Legit" in the sense of being a real, identifiable, operating business with public policies is different from "effective" or "safe," and this review doesn't use the former to imply the latter.
Who Might Want to Research DEFY IT Further
DEFY IT is built around a specific kind of day, not a specific person - the brand markets its tablets primarily to:
Gamers grinding through extended sessions
Athletes training through fatigue
Creators working long hours to hit a deadline
Professionals running on heavy, back-to-back schedules
If that's the kind of week you're having, you're at least the audience DEFY IT is talking to - whether the product itself is the right call is a separate question, and the sections above (ingredients, pricing, the DEA's 7-OH action, and the money-back guarantee's fine print) are the ones worth reading before deciding. That's the brand's own targeting, not a recommendation we're making. Given the FDA's current regulatory position on kratom and the safety and dependence concerns regulators have raised, anyone considering DEFY IT or any kratom product should first speak with a healthcare professional, particularly if pregnant, nursing, under 18, taking other medications, or managing an existing medical condition.
How This DEFY IT Review Was Researched
This review considered:
DEFY IT's own marketing landing page
ETHA's checkout and product pages for Level-Up and Respawn
ETHA's published shipping, terms of service, privacy, and refunds/returns policies
The FDA's and DEA's publicly stated current positions on kratom and 7-OH
Independent kratom-law trackers, cross-referenced for state-ban accuracy
Statements are separated into three categories throughout this article:
Confirmed: information verified directly from a current source, such as a listed price or refund timeframe.
Brand-stated: what DEFY IT or ETHA says about its own product, such as claimed effects or comparative safety.
Not independently verified: what this review could not confirm, such as the exact composition of a specific batch.
Where a meaningful discrepancy existed between sources - such as the pricing difference between DEFY IT's landing page and ETHA's checkout, or the conflicting shipping-restriction lists - this review reports the discrepancy rather than resolving it in the brand's favor.
Frequently Asked Questions
Is DEFY IT FDA approved?
No. DEFY IT is not an FDA-approved drug, and the FDA states that kratom is not lawfully marketed as a dietary supplement.
What is DEFY IT?
DEFY IT is an ETHA product line featuring pressed whole-leaf Mitragyna speciosa tablets sold primarily as Level-Up and Respawn.
Who makes DEFY IT?
DEFY IT is operated by Ethos Natural Medicine LLC, doing business as Etha™ Natural Medicine, based in El Cajon, California.
Is DEFY IT a dietary supplement?
DEFY IT's own site describes its botanicals as not classified or approved by the FDA as a dietary ingredient. This review refers to DEFY IT as a kratom botanical product rather than a conventional dietary supplement for that reason.
What is the difference between Level-Up and Respawn?
DEFY IT markets Level-Up around endurance and focus, while Respawn is positioned around recovery and reset; both are whole-leaf kratom tablet products containing the same 300 mg of Mitragyna speciosa leaf per tablet.
Does DEFY IT contain synthetic or concentrated 7-OH?
DEFY IT states that its tablets keep 7-hydroxymitragynine at naturally occurring trace levels and do not contain synthetic or concentrated 7-OH. This review did not independently verify that claim against a specific batch certificate of analysis.
Is DEFY IT affected by the DEA's 7-OH scheduling action?
The DEA's July 2026 action targets concentrated and synthetic 7-OH products, not natural whole-leaf kratom with only trace 7-OH - a distinction both DEA and FDA have stated explicitly. Based on DEFY IT's own description of its formulation as whole-leaf with trace 7-OH, its stated product would fall outside that action's stated scope, though this review did not independently test DEFY IT's batches against the proposed threshold, and the underlying regulatory process is still open.
How much does DEFY IT cost?
At the time of this review, DEFY IT's landing page listed Level-Up and Respawn at $17.49 each and the four-package bundle at $49.99, while ETHA's own storefront listed both individual products at $18.49 each and the Defy It Bundle at $52.99. Because the two pages were not synchronized, all pricing should be treated as time-sensitive and confirmed directly before purchase.
Does DEFY IT have a money-back guarantee?
ETHA advertises a 30-Day Money Back Guarantee, subject to conditions including original packaging, usage limits, and first-purchase eligibility. See the refund policy section above for details.
Does DEFY IT publish lab results or COAs?
DEFY IT states that batch certificates of analysis are accessible via QR code or bag number on its packaging. This review did not independently pull a specific batch COA.
Where can DEFY IT be purchased, and what is the official website?
DEFY IT's official marketing site is defyithealth.com, with checkout completed through ETHA's storefront at ethanaturals.com. Readers can also review current offer information through the link in this article, which may be a commercial or affiliate destination rather than the brand's own site directly.
Where does DEFY IT ship, and is kratom legal everywhere in the United States?
DEFY IT's own published policies list overlapping but inconsistent sets of restricted U.S. states, cities, and counties, and kratom's legal status varies independently by state and locality. Independent research for this review also found state bans, including Tennessee's (effective July 1, 2026), that aren't fully reflected in DEFY IT's own lists. Confirm current shipping availability directly with the seller and independently check your own state and local kratom laws before ordering - don't rely solely on a seller's restriction list.
Bottom Line: What Is Confirmed About DEFY IT in 2026
DEFY IT is an ETHA-branded line of pressed whole-leaf kratom tablets, sold as Level-Up and Respawn, marketed around focus, endurance, and recovery for people with demanding physical or mental workloads. What can be confirmed directly from current sources:
The product is Mitragyna speciosa leaf pressed into 500 mg tablets containing 300 mg of leaf each.
It's sold by Ethos Natural Medicine LLC dba Etha Natural Medicine.
Price ranged $17.49-$18.49 per 100-tablet package depending on the page checked at the time of this review.
It's backed by a conditional 30-day money-back guarantee.
ETHA's checkout pages carry a California Proposition 65 lead-exposure warning.
What remains manufacturer marketing rather than independently established fact: claims about a "natural safety ceiling," reduced dependence, specific focus or reaction-time benefits, and muscle-recovery or discomfort-relief outcomes. Kratom products, including DEFY IT, are not FDA-approved drugs and are not currently recognized by the FDA as lawful dietary supplements. Separately, the DEA's July 2026 move to temporarily schedule concentrated and synthetic 7-OH is, by both agencies' own description, aimed at that concentrated/synthetic category rather than natural whole-leaf kratom - a distinction that matters for DEFY IT's stated formulation but doesn't amount to approval, endorsement, or a settled final rule. This review also found state-level kratom bans - including Tennessee's, effective July 1, 2026 - that aren't yet reflected in DEFY IT's own published shipping and restriction lists, underscoring that a seller's list should never substitute for checking current state law.
Anyone considering DEFY IT should:
Review the current certificate of analysis for their specific batch.
Confirm their state and local law independently.
Read the current refund policy in full.
Consult a healthcare professional before use.
Contact Information
Email: [email protected] / Responds withing 24 hours
Phone: (800) 862-0341
Hours: Mon - Fri 10am-5pm PDT
Company Address: Ethos Natural Medicine 1148 N. Melrose Dr. Suite B Vista, CA 92083 USA
Review DEFY IT's product pages and testing disclosures here.
Disclosures: This is a paid advertorial and commercial/editorial content; affiliate links may earn a commission at no additional cost to the reader. This article is general information only and is not medical advice, diagnosis, or treatment. No implication of FDA approval is made or intended for any product discussed. Claims attributed to DEFY IT or ETHA belong to the brand and have not been independently verified by this publication unless stated otherwise. Prices, subscriptions, promotions, and availability can change without notice. Kratom's legal status varies by jurisdiction and can change. Personal experiences and testimonials referenced from the brand's site are individual and anecdotal and do not establish typical outcomes for other consumers.
SOURCE: DEFY IT Health